Rubicon Research Company Description

Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally.

The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant.

Its primary proprietary technologies for drug delivery comprising RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption, as well as RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies.

The company was incorporated in 1999 and is headquartered in Mumbai, India.

Rubicon Research Limited

Country	India
Founded	1999
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	1,290
CEO	Parag Sancheti

Contact Details

Address: MedOne House Mumbai, Maharashtra 400604 India
Phone	91 22 6141 4000
Website	rubicon.co.in

Stock Details

Ticker Symbol	RUBICON
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE506V01022
SIC Code	2834

Key Executives

Name	Position
Parag Suganchand Sancheti	Chief Executive Officer and Executive Director
Pratibha S. Pilgaonkar	Co-Founder, MD and Director
Deepashree Omkar Tanksale	Company Secretary and Compliance Officer
Nitin Jajodia	Chief Commercial Officer
Sudhir Dhirendra Pilgaonkar	Co-Founder, Chief Commercial Officer and Senior Vice President
Rohit Saraogi	Chief Financial Officer
Sumant Sudhir Pilgaonkar	Senior Vice President of Operations
Romola Pinto	Vice President of Human Resources and Administration
Avani Harish Shah	General Manager of Secretarial, Legal and Compliance
Sagar Pradeep Oak	Senior Vice President of Corporate Development and Strategy